Literature DB >> 3339304

Microbiology of adult cellulitis.

D M Lutomski1, A T Trott, J M Runyon, C I Miyagawa, J L Staneck, J O Rivera.   

Abstract

Needle aspiration of cellulitis sites is commonly advocated to assist in the identification of causative organisms. Twenty-five nondiabetic, adult patients with a clinical diagnosis of cellulitis had site aspirations and blood cultures obtained before antibiotic therapy was initiated. Site cultures were positive in 6 of 25 patients. Blood cultures were positive in 4 of 25 patients. All organisms except one (Enterobacter agglomerans) were staphylococci or streptococci. The gram-negative bacilli were not believed to be a pathogen based on the patient's prompt response to nafcillin. In adult patients who do not have complications, the use of needle aspiration was not supported. Empiric treatment of cellulitis aimed at gram-positive cocci appears to be sufficient.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3339304

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  5 in total

1.  Diagnosis of cellulitis in the immunocompromised host.

Authors:  C F Carey; L Dall
Journal:  Can J Infect Dis       Date:  1990

2.  Diagnosis of cellulitis in patients infected with the human immunodeficiency virus.

Authors:  I Diaz; S Neelagaru; L Dall
Journal:  Can J Infect Dis       Date:  1994-03

Review 3.  Drug treatment of skin and soft tissue infections in elderly long-term care residents.

Authors:  B H Lertzman; A A Gaspari
Journal:  Drugs Aging       Date:  1996-08       Impact factor: 3.923

Review 4.  Bacterial skin infections in the elderly: diagnosis and treatment.

Authors:  Simone Laube; Anne M Farrell
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

5.  Risk factors for bacteremia in patients with limb cellulitis.

Authors:  G Peralta; E Padrón; M P Roiz; I De Benito; J C Garrido; F Talledo; M J Rodríguez-Lera; L Ansorena; M B Sánchez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-10       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.